Using New Sealant and Adhesive Polymer to Enable Atraumatic Surgical Procedures for Tissue Repair with Maria Pereira TISSIUM TRANSCRIPT
Download PDFSep 13, 2023
Maria Pereira Co-Founder and Chief Innovation Officer at TISSIUM, discusses her journey to develop a biocompatible, biodegradable polymer to enable atraumatic surgical procedures for tissue repair. This new polymer technology can be used as a sealant and adhesive to replace the use of tacks and sutures to repair blood...
Sep 13, 2023
Maria Pereira Co-Founder and Chief Innovation Officer at TISSIUM, discusses her journey to develop a biocompatible, biodegradable polymer to enable atraumatic surgical procedures for tissue repair. This new polymer technology can be used as a sealant and adhesive to replace the use of tacks and sutures to repair blood...
Advanced Continuous Glucose Monitoring and Personalized Dosing of Insulin for Type 1 Diabetes with Que Dallara Medtronic TRANSCRIPT
Download PDFJul 26, 2023
Que Dallara, Executive Vice President and President of the Diabetes Operating Unit at Medtronic, is enthusiastic about the MiniMed 780G system, a recently FDA approved solution for people with type 1 diabetes. This system has a continuous glucose monitor, insulin pump, and mobile app that connects with CareLink, which...
Jul 26, 2023
Que Dallara, Executive Vice President and President of the Diabetes Operating Unit at Medtronic, is enthusiastic about the MiniMed 780G system, a recently FDA approved solution for people with type 1 diabetes. This system has a continuous glucose monitor, insulin pump, and mobile app that connects with CareLink, which...
Micro Insert Treats Prevents Progression of Retinal Eye Diseases with Nancy Lurker EyePoint Pharmaceuticals TRANSCRIPT
Download PDFJun 29, 2023
Nancy Lurker, CEO and Board Director of EyePoint Pharmaceuticals, aims to prevent the progression of blindness by developing technology that addresses retinal eye diseases. These back of the eye diseases are age-related and an increasing threat to populations worldwide. Current treatments require regular injections in...